TI
JBIO

Trexquant Investment’s Jade Biosciences JBIO Stock Holding History

Trexquant Investment’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
68,316
+40,209
+143% +$839K 0.01% 1317
2026
Q1 		$395K Buy
+28,107
New +$407K ﹤0.01% 1533

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's JBIO Position: Q2 2026 in Review

Trexquant Investment increased its Jade Biosciences (JBIO) stake by 143% in Q2 2026, buying an estimated $839K and bringing the position to 68,316 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #1317.

Trexquant Investment first reported a position in JBIO in Q1 2026 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Trexquant Investment held 68,316 shares of Jade Biosciences worth $1.52M as of Q2 2026.
  • Trexquant Investment bought 40,209 Jade Biosciences shares in Q2 2026, an estimated $839K.
  • Jade Biosciences made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1317 holding.
  • Trexquant Investment first reported a position in Jade Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.